We speculate that the more aggressive course of renal failure in patients with SMARCAL1-associated disease relative to podocin deficiency—which exclusively affects the podocyte—may be related to additional functional effects of defective SMARCAL1 expressed in other nephron structures. Here, SMARCAL1 is linked to acute kidney injury.